Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...
Le Lézard41m
Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model
Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that its contract with the CMS Innovation Center (CMMI) for use of the Patient Activation Measure® (PAM) has been ...
Bionomics Limited announces intention to re-domicile to the United States
To implement the re-domiciliation, Bionomics has entered into a Scheme Implementation Agreement with Neuphoria. Following the implementation of the Scheme, Neuphoria will become the ultimate parent ...
news.crunchbase32m
The 10 Biggest Rounds Of September: Safe Superintelligence’s $1B Raise Reigns Supreme
AI startup Safe Superintelligence’s $1 billion round — for a startup that’s existed for only a few months — easily led the ...